Brittany Ryan's Video Answer of the Week: Remaining Positive

Brittany Ryan was wrapping up her senior year in college and about ready to do what hundreds of thousands of people her age do every fall: begin the next, post-educational stage of her life by looking for a job and getting her future underway.

Cancer had other ideas.

That summer, Brittany was diagnosed with stage 4-B Hodgkin's lymphoma.

As her friends began new and exciting chapters in their lives, she began chemotherapy.

But that isn't all she did. She also launched a campaign, Live.Laugh.Lymphoma, to bring awareness to blood disorders and to help raise money for the Lymphoma Research Foundation.

Just recently, her doctors told her the good news: she was in remission. Knowing full well that that wasn't the end of it, Brittany has begun publishing weekly videos in which she answers questions about her treatment, her disease, her campaign, and many other things that people in this community want to know.

The Lymphoma Information Network will be featuring her weekly answer videos, and along the way finding out more about Brittany's experiences as a Hodgkin's patient.

This week, she discusses how she has maintained such an optimistic outlook throughout her journey, and she reflects on how having Hodgkin's has fundamentally changed her.

Don't forget to visit her homepage, Live.Laugh.Lymphoma for more information and check out her Facebook page.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap